Ebola Vaccine Trial Begins in DR Congo: Ervebo to Be Tested Against Bundibugyo Virus
The WHO-backed Tumaini trial in DR Congo will assess Ebola vaccine candidates, including Ervebo, against the Bundibugyo strain. Understand its clinical approach and significance for global health.
The Democratic Republic of Congo, which is also referred to as the DR Congo, has started the its Tumaini clinical study on October 23, 2026, to find out if the vaccines that already exist or are being developed offer protection from the Bundibugyo st... [3191 chars]
Read the full report on Adda247
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Adda247
- Published
- Monday, 26 October 2026, 4:20 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Adda247 with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
